Izvorni kod stranice Lisergamid

[[Amid]]i [[liserginska kiselina|liserginske kiseline]] su kolektivno poznati kao ''lisergamidi''.<ref>Hofmann A. Psychotomimetic Drugs: Chemical and Pharmacological Aspects. ''Acta. Physiol. Pharmacol. Neerlandica''. 1959;8:240-258.</ref><ref>{{cite patent
 | country = US
 | number = 2997470
 | status = patent
 | title = LYSERGIC ACID AMIDES
 | pubdate = 5. 3. 1956.
 | gdate = 22. 8. 1961.
 | inventor = Richard P. Pioch
}}</ref><ref>David E. Nichols. LSD and Its Lysergamide Cousins. ''The Heffter Review of Psychedelic Research''. 2001;2:80-87.</ref>

[[Datoteka:Lysergamides.svg|frame|right|Opšta strukture Lisergamida]]

Lisergamidi, tabelarno po strukturi
{| border=1
!Ime !! R1 !! R6 !! R2 !! R3
|-
| [[Ergine|LSA]] / LAA || H || [[Metil|CH<sub>3</sub>]] || H || H
|-
| [[DAM-57]] || H || CH<sub>3</sub> || CH<sub>3</sub> || CH<sub>3</sub>
|-
| [[Ergonovin]] || H || CH<sub>3</sub> || CH(CH<sub>3</sub>)CH<sub>2</sub>OH || H
|-
| [[Metergin]] || H || CH<sub>3</sub> || CH(CH<sub>2</sub>CH<sub>3</sub>)CH<sub>2</sub>OH || H 
|-
| [[Metisergid]] || CH<sub>3</sub> ||  CH<sub>3</sub> || CH(CH<sub>2</sub>CH<sub>3</sub>)CH<sub>2</sub>OH || H 
|-
| [[LAE-32]] || H || CH<sub>3</sub> || [[Etil grupa|CH<sub>2</sub>CH<sub>3</sub>]] || H 
|-
| [[Liserginska kiselina 2-butil amid|LSB]] || H || CH<sub>3</sub> || CH(CH<sub>3</sub>)CH<sub>2</sub>CH<sub>3</sub> || H 
|-
| [[Liserginska kiselina 3-pentil amid|LSP]] || H || CH<sub>3</sub> || CH(CH<sub>2</sub>CH<sub>3</sub>)CH<sub>2</sub>CH<sub>3</sub> || H 
|-
| [[Dialolisergamid|DAL]] || H || CH<sub>3</sub> || [[Alil|H<sub>2</sub>C=CH-CH<sub>2</sub>]] || Alil|H<sub>2</sub>C=CH-CH<sub>2</sub>
|-
| [[Metilizopropillisergamid|MIPLA]] || H || CH<sub>3</sub> || [[Izopropil|CH(CH<sub>3</sub>)<sub>2</sub>]] || CH<sub>3</sub>
|-
| [[Etilizopropilisergamid|EIPLA]] || H || CH<sub>3</sub>  || CH(CH<sub>3</sub>)<sub>2</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[Metilpropilisergamid|LAMP]] || H || CH<sub>3</sub> || CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> || CH<sub>3</sub>
|-
| '''[[LSD]]''' / [[LSD|LAD]] || H || CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub> 
|-
| [[ETH-LAD]] || H || CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub> ||  CH<sub>2</sub>CH<sub>3</sub> 
|-
| [[PARGY-LAD]] || H || [[Propinil|HC≡C−CH<sub>2</sub>]] ||  CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[AL-LAD]] || H || H<sub>2</sub>C=CH-CH<sub>2</sub> ||  CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[PRO-LAD]] || H || [[Propil|CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>]] || CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[CYP-LAD]] || H || [[Ciklopropil|C<sub>3</sub>H<sub>5</sub>]] || CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[BU-LAD]]  || H || [[Butil|CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>]]  ||  CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[ALD-52]] || [[Acetil|COCH<sub>3</sub>]] || CH<sub>3</sub> ||  CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[MLD-41]] || CH<sub>3</sub> || CH<sub>3</sub> ||  CH<sub>2</sub>CH<sub>3</sub> || CH<sub>2</sub>CH<sub>3</sub>
|-
| [[LSM-775]] || H || CH<sub>3</sub> || colspan=2|[[Morfolin|CH<sub>2</sub>CH<sub>2</sub>-O-CH<sub>2</sub>CH<sub>2</sub>]]
|-
| [[LPD-824]] || H || CH<sub>3</sub> || colspan=2|[[Pirolidin|CH<sub>2</sub>CH<sub>2</sub>
CH<sub>2</sub>CH<sub>2</sub>]]
|-
| [[LSD-Pip]] || H || CH<sub>3</sub> || colspan=2|[[Piperidin|CH<sub>2</sub>CH<sub>2</sub>
CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>]]
|-
| [[Liserginska kiselina 2,4-dimetilazetidid|LA-SS-Az]] || H || CH<sub>3</sub> || colspan=2|CH<sub>2</sub>(CHCH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>
|}

== Reference ==
{{reflist}}
{{-}}
{{Adrenergici}}
{{Dopaminergici}}
{{Serotonergici}}

[[Kategorija:Lisergamidi]]